| 2015 |
CHMP1B and IST1 form a one-start, double-stranded helical copolymer resolved at 4 Å resolution by cryo-EM. The inner strand comprises 'open' CHMP1B subunits that interlock in an elaborate domain-swapped architecture, encircled by an outer strand of 'closed' IST1 subunits. Unlike other ESCRT-III proteins, this CHMP1B/IST1 polymer forms external coats on positively curved membranes in vitro and in vivo, indicating a distinct membrane curvature-sensing and -stabilizing mechanism. |
4 Å cryo-EM reconstruction of helical copolymer; in vitro and in vivo membrane-binding assays |
Science (New York, N.Y.) |
High |
26634441
|
| 2008 |
The C-terminal tail of CHMP1B binds the MIT domain of spastin through a noncanonical site between the first and third helices of the MIT domain, forming a high-affinity complex (2.5 Å crystal structure). Point mutations in the CHMP1B-binding site of spastin block spastin recruitment to the midbody and impair cytokinesis, establishing CHMP1B as the midbody-targeting signal for spastin. |
2.5 Å X-ray crystal structure of CHMP1B C-terminal tail / spastin MIT domain complex; spastin point mutants; fluorescence microscopy of midbody localization; cytokinesis assay |
Nature structural & molecular biology |
High |
18997780
|
| 2004 |
CHMP1B interacts with spastin via the spastin MIT domain (residues 80–196). Co-immunoprecipitation, in vitro pull-down, beta-lactamase protein fragment complementation, and co-localization in Cos-7 and PC12 cells confirmed the interaction. Expression of CHMP1B prevented the abnormal microtubule phenotype caused by ATPase-defective spastin, indicating CHMP1B functionally modulates spastin activity in membrane trafficking. |
Yeast two-hybrid; co-IP; in vitro pull-down; beta-lactamase fragment complementation; immunofluorescence co-localization; dominant-negative spastin phenotype rescue |
Human molecular genetics |
High |
15537668
|
| 2009 |
CHMP1B forms higher-order helical structures in vitro and interacts with IST1; IST1-CHMP1B interactions are required for cytokinetic abscission. The autoinhibitory alpha5 helix folds back against the ESCRT-III core domain, and its dissociation activates ESCRT-III proteins for membrane assembly. |
In vitro helical polymer assembly; biochemical interaction assays; mutagenesis of CHMP3 core-alpha5 interface; abscission functional assay; crystal structures of IST1 and CHMP3 N-terminal core domains |
Nature structural & molecular biology |
High |
19525971
|
| 2005 |
The VPS4A MIT domain binds the C-terminal half of CHMP1B with a Kd of ~20 µM. NMR solution structure of VPS4A MIT domain shows that a conserved leucine (Leu-64) on the third helix, which normally binds a fourth helix in TPR motifs, is used to bind CHMP1B, suggesting ESCRT-III proteins complete the TPR motif. |
NMR solution structure; surface plasmon resonance / binding affinity measurement; mutational analysis |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16174732
|
| 2006 |
CHMP1B is a direct binding partner of the deubiquitinating enzyme AMSH; VPS4 and AMSH compete for binding to the C-terminal regions of CHMP1B, suggesting coordinated regulation of ESCRT-III disassembly and endosomal cargo deubiquitination. |
Co-immunoprecipitation; competitive binding assay between VPS4 and AMSH for CHMP1B C-terminus |
The Journal of biological chemistry |
Medium |
16760479
|
| 2007 |
The MIT domain of UBPY/USP8 binds CHMP1B (and CHMP1A) among the 11 human CHMP family members. The UBPY MIT domain is essential for endosomal localization and for its functional role in EGF receptor degradation. |
Co-immunoprecipitation; UBPY MIT-deletion mutant localization and functional assay; EGFR degradation rescue assay |
The Journal of biological chemistry |
Medium |
17711858
|
| 2008 |
LIP5 binds CHMP1B; in CHMP1B (and CHMP2A), the LIP5 binding site encompasses C-terminal sequences that overlap with MIT-interacting motifs (MIMs) used by VPS4, but evidence for a second VPS4-binding site in CHMP1B suggests LIP5 and VPS4 can bind simultaneously. LIP5 preferentially binds polymerized CHMP2A but soluble CHMP5, indicating conformation-dependent regulation. |
In vitro binding assays; pull-down with truncation mutants; analysis of MIM overlap |
Molecular biology of the cell |
Medium |
18385515
|
| 2010 |
C-terminal fragments of CHMP1B (along with other ESCRT-III proteins) activate purified human VPS4A ATPase activity; this activation requires both the MIT-interacting motif and ~50 adjacent amino acids, and mutating VPS4A pore loops alters the response, supporting a model where ESCRT-III proteins thread into the VPS4A pore to stimulate oligomerization and catalysis. |
In vitro ATPase activity assay with purified proteins; VPS4A pore-loop mutagenesis; liposome-based oligomerization assay |
The Journal of biological chemistry |
Medium |
20805225
|
| 2012 |
The first MIT module of the tandem LIP5 MIT domain binds CHMP1B through canonical type 1 MIT-interacting motif (MIM1) interactions. LIP5 can bind MIM1-containing ESCRT-III proteins (including CHMP1B), CHMP5, and VPS4 independently in vitro, but in cells stable VPS4 complex assembly requires LIP5 to simultaneously contact both a MIM1-containing protein and CHMP5. |
Solution NMR structure of LIP5-CHMP5 complex; SPR binding measurements; co-immunoprecipitation in cells |
The Journal of biological chemistry |
High |
23105106
|
| 2012 |
MITD1 interacts strongly with CHMP1B (and CHMP2A and IST1); CHMP1B and these ESCRT-III subunits are required for recruitment of MITD1 to the midbody, and MITD1 participates in the abscission phase of cytokinesis by negatively regulating IST1-VPS4 interaction. |
Co-immunoprecipitation; siRNA knockdown with midbody localization readout; cytokinesis abscission assay |
Molecular biology of the cell |
Medium |
23015756
|
| 2015 |
Crystal structure at 1 Å resolution of the LIP5 N-terminal domain (LIP5NTD) in complex with MIM motifs of both CHMP5 and CHMP1B reveals that ESCRT-III binding induces a conformational change in LIP5NTD via insertion of CHMP5 Tyr182 at the LIP5 core; mutation of Tyr182 partially relieves CHMP5-dependent inhibition of LIP5-mediated VPS4 stimulation. |
1 Å X-ray crystal structure; mutagenesis; VPS4 ATPase stimulation assay |
The Journal of biological chemistry |
High |
25637630
|
| 2018 |
CHMP1B is ubiquitinated within a flexible loop that undergoes conformational changes during polymerization; it is deubiquitinated by USP8/UBPY and found fully devoid of ubiquitin in a ~500 kDa complex containing IST1. EGF stimulation transiently increases ubiquitinated CHMP1B on cell membranes. CHMP1B ubiquitination is required for EGFR trafficking in human cells and wing development in Drosophila. |
Ubiquitination assay; co-immunoprecipitation with USP8; size-exclusion chromatography (500 kDa complex); EGF stimulation pulse-chase; Drosophila genetic loss-of-function; EGFR trafficking assay |
PLoS genetics |
High |
29933386
|
| 2019 |
M1 Spastin recruits ESCRT-III proteins IST1 and CHMP1B to lipid droplets via its MIT domain to facilitate fatty acid trafficking from lipid droplets to peroxisomes. Loss of IST1 or CHMP1B impairs LD-to-peroxisome FA trafficking and lipid peroxidation relief. |
Fluorescence live imaging; co-localization; loss-of-function (siRNA/KO); fatty acid trafficking assay; lipid peroxidation assay |
The Journal of cell biology |
Medium |
31227594
|
| 2019 |
HeLa cells lacking CHMP1B (or IST1) develop cellular protrusions, a phenotype also seen in spastin-null cells. The protrusion phenotype requires protrudin and KIF5, placing CHMP1B in the ESCRT-III/spastin axis that limits polarised protrudin-dependent endosomal motility to cell protrusions. |
siRNA knockdown in HeLa cells; epistasis with spastin/IST1/protrudin/KIF5 knockdown; fluorescence microscopy of protrusion phenotype; BMP receptor distribution assay |
Cellular and molecular life sciences : CMLS |
Medium |
31587092
|
| 2020 |
LZTR1 (a CUL3 ubiquitin ligase adaptor) controls ubiquitination of CHMP1B and thereby regulates dynamics of fusion and fission of recycling endosomes; Noonan syndrome-associated LZTR1 mutations reduce CHMP1B ubiquitination, leading to endosomal accumulation and sustained VEGFR2 signaling. |
Co-immunoprecipitation; ubiquitination assay; LZTR1 knockout mouse and endothelial cell knockdown; endosomal trafficking imaging; VEGFR2 signaling readout |
Circulation research |
Medium |
32175818
|
| 2011 |
Calpain-7 binds CHMP1B at its second α-helical region (not the canonical C-terminal MIM1) via its tandem MIT domain (CL7MIT). Coexpression of CHMP1B enhances calpain-7 autolysis, and further coexpression of IST1 forms a ternary calpain-7/CHMP1B/IST1 complex. Overexpression of CHMP1B and IST1 together increases calpain-7 in membrane/organelle fractions. |
In vitro pull-down with truncation mutants; co-immunoprecipitation; calpain-7 autolysis assay; subcellular fractionation |
Journal of biochemistry |
Medium |
21616915
|
| 2023 |
A small-molecule pseudonatural product that specifically disrupts IST1-CHMP1B interaction inhibits IST1-CHMP1B copolymer formation, blocks transferrin receptor recycling (causing transferrin accumulation in stalled sorting endosomes), and triggers noncanonical LC3 lipidation on stalled endosomes. The compound does not affect cytokinesis, MVB sorting, or extracellular vesicle biogenesis. |
Chemical inhibitor screen; Co-IP/interaction assay; transferrin receptor recycling assay; LC3 lipidation assay; cytokinesis and MVB assays as negative controls |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
38635626
|
| 2023 |
IST1 and CHMP1B together contribute to scission of early endosomal tubular carriers; SNX15 and CHMP1B alternately recruit IST1 to distinct subdomains of sorting endosomes (clathrin subdomain vs. base of endosomal tubules), regulating transferrin receptor and mannose-6-phosphate receptor recycling. |
Live-cell microscopy; siRNA depletion; kinetic and spatial trafficking assays for transferrin receptor and M6PR; co-localization with endosomal markers |
Traffic (Copenhagen, Denmark) |
Medium |
37926552
|
| 2023 |
CHMP1B exhibited nuclear localization in mammalian cells and recruited both human and Asgard VPS4 to nuclear foci; mutation of the ESCRT-III N-terminal region abolished these nuclear properties, indicating the N-terminal domain mediates nuclear targeting and chromatin association. |
Fluorescence microscopy of nuclear localization; mutagenesis of N-terminal region; interspecies VPS4 recruitment assay |
The ISME journal |
Low |
36221007
|
| 2023 |
Cryo-EM of brominated lipids within CHMP1B/IST1-coated membrane nanotubes revealed leaflet-level structural asymmetries: constricted membranes show altered lipid diffusion, leaflet thinning, lipid compositional/conformational asymmetry, and two CHMP1B phenylalanine residues create a helical hydrophobic defect on the outer leaflet where polyunsaturated docosahexaenoyl tails accumulate. |
Cryo-EM with brominated lipid contrast probes; molecular dynamics simulation; reconstituted CHMP1B/IST1 nanotubes |
Nature structural & molecular biology |
High |
36624348
|
| 2022 |
HCV infection enhances the interaction between CHMP1B and VPS4A (but not VPS4B) via HCV-induced polyubiquitylation of VPS4A at K23 and K121; VPS4A K23R/K121R mutant fails to interact with CHMP1B and has reduced ATPase activity, indicating that VPS4A ubiquitylation promotes CHMP1B binding and VPS4A activation for HCV particle release. |
Co-immunoprecipitation; site-directed mutagenesis (VPS4A K23R/K121R); ATPase activity assay; siRNA knockdown; viral infectivity titer |
Journal of virology |
Medium |
35044214
|
| 2025 |
CHMP2A knockout reveals an ordered, hierarchical assembly of ESCRT-III at the cytokinetic abscission site: IST1 and CHMP2B are minimally disrupted, while CHMP1B (along with CHMP4B and CHMP3) shows progressively severe mislocalization, establishing CHMP2A as an upstream organizer required for correct CHMP1B positioning during abscission. |
CHMP2A knockout; live-cell imaging; structured illumination microscopy (SIM); correlative light-electron microscopy; dual-protein imaging of ESCRT-III subunits |
Molecular biology of the cell |
Medium |
40928930
|
| 2022 |
Conserved leucine residues L192 and L195 within the MIM (MIT-interacting motif) domain of CHMP1B are required for interaction with USP8/UBPY, whereas the ubiquitination status of CHMP1B does not affect this interaction; deletion of the MIM domain abolishes binding. |
HTRF interaction assay; CHMP1B point-mutant and deletion analysis (L192A/L195A and MIM deletion); comparison of ubiquitin-deficient CHMP1B mutant (4K→R) vs wild-type binding to USP8 |
SLAS discovery : advancing life sciences R & D |
Medium |
35995394
|
| 2011 |
Calpain-7 N-terminal tandem MIT domain directly interacts with CHMP1B; the interaction was confirmed by pulldown assay using recombinant proteins. Overexpression of GFP-CHMPs or dominant-negative VPS4B caused calpain-7 accumulation in perinuclear puncta overlapping with endocytosed EGF, and endogenous calpain-7 partitions largely to cytosol with a small fraction in particulate fractions. |
Strep-tag pulldown from stable HEK293T transfectants; recombinant protein pulldown; fluorescence microscopy; subcellular fractionation |
Journal of biochemistry |
Medium |
18316332
|
| 2023 |
CHMP1B (along with CHMP1A, CHMP5, and IST1 as accessory ESCRT-III proteins) is required for intraluminal vesicle formation in Drosophila recycling endosomes but, unlike core ESCRTs, is not involved in degradation of ubiquitinated proteins in late endosomes, revealing a specific ubiquitin-independent role in Rab11a-exosome generation. |
Drosophila genetic knockdown; comparative proteomics of Rab11a-enriched vs. total exosome preparations; CHMP5 siRNA knockdown in HCT116 cells; ILV formation assay |
Journal of extracellular vesicles |
Medium |
36872252
|